https://mitsui-global.com/news/ 2026-06-04T01:03:18+00:00 https://mitsui-global.com/ja/%e3%83%8b%e3%83%a5%e3%83%bc%e3%82%b9/ 2026-06-04T01:03:18+00:00 https://mitsui-global.com/cipia-announces-ipo/ 2022-04-22T15:35:59+00:00 https://mitsui-global.com/wp-content/uploads/2021/11/Cipia-team-image1.jpg https://mitsui-global.com/spire-to-expand-footprint-by-acquiring-exactearth/ 2022-04-22T15:36:31+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/spire-globe.jpg https://mitsui-global.com/spire-goes-public-through-spac/ 2022-04-22T15:36:43+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/spire-global-04.jpg https://mitsui-global.com/valens-completes-form-f-4-registration-in-preparation-of-spac-merger-with-ptk-acquisition-corp/ 2022-04-22T15:37:00+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/valens-news.jpg https://mitsui-global.com/rallybio-goes-public/ 2022-04-22T15:37:20+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/rallybio-news.jpg https://mitsui-global.com/rallybio-reports-positive-data-in-its-clinical-program-for-the-prevention-of-fetal-and-neonatal-alloimuune-thrombocytopenia-fnait/ 2022-04-22T16:26:13+00:00 https://mitsui-global.com/wp-content/uploads/2022/01/rally-bio-conference-room.jpg https://mitsui-global.com/ja/rallybio%e3%81%af%e8%87%aa%e7%a4%be%e3%81%ae%e8%87%a8%e5%ba%8a%e3%83%97%e3%83%ad%e3%82%b0%e3%83%a9%e3%83%a0%e3%81%ab%e3%81%a6%e8%83%8e%e5%85%90%e3%83%bb%e6%96%b0%e7%94%9f%e5%85%90%e5%90%8c%e7%a8%ae/ 2022-04-22T16:26:13+00:00 https://mitsui-global.com/wp-content/uploads/2022/01/rally-bio-conference-room.jpg https://mitsui-global.com/ensem-therapeutics-raises-67-million-in-series-a-financing-to-develop-small-molecule-medicines-for-difficult-to-drug-targets/ 2022-04-22T16:46:55+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/beakers.jpg https://mitsui-global.com/ja/ensem-therapeutics%e3%81%af%e3%80%81%e3%82%a2%e3%83%b3%e3%83%89%e3%83%a9%e3%83%83%e3%82%ac%e3%83%96%e3%83%ab%e3%81%a8%e3%81%95%e3%82%8c%e3%81%a6%e3%81%8d%e3%81%9f%e3%82%bf%e3%83%bc%e3%82%b2%e3%83%83/ 2022-04-22T16:46:55+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/beakers.jpg https://mitsui-global.com/cipia-and-intcomex-partner-to-support-increasing-demand-for-fleet-management-and-driver-monitoring/ 2022-04-22T17:39:31+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/LATAM-Cipia-DriverSense-e1650649252235.png https://mitsui-global.com/ja/cipia-%e3%81%af%e6%96%b0%e8%a6%8f%e6%a0%aa%e5%bc%8f%e5%85%ac%e9%96%8b%e3%82%92%e7%99%ba%e8%a1%a8%e3%81%97%e3%81%be%e3%81%97%e3%81%9f%e3%80%82-2/ 2022-04-22T20:28:56+00:00 https://mitsui-global.com/wp-content/uploads/2021/11/Cipia-team-image1.jpg https://mitsui-global.com/cipia-announces-design-win-with-new-chinese-oem/ 2022-04-22T20:29:18+00:00 https://mitsui-global.com/wp-content/uploads/2022/03/cipia-driver-sense.jpg https://mitsui-global.com/ja/cipia%e3%81%af%e4%b8%ad%e5%9b%bd%e3%81%ae%e6%96%b0%e3%81%97%e3%81%84oem%e3%81%ab%e8%87%aa%e7%a4%be%e8%a3%bd%e5%93%81%e3%81%8c%e6%8e%a1%e7%94%a8%e3%81%95%e3%82%8c%e3%81%9f%e4%ba%8b%e3%82%92%e7%99%ba/ 2022-04-22T20:29:19+00:00 https://mitsui-global.com/wp-content/uploads/2022/03/cipia-driver-sense.jpg https://mitsui-global.com/valens-goes-public-on-the-new-york-stock-exchange/ 2022-04-22T20:43:44+00:00 https://mitsui-global.com/wp-content/uploads/2021/10/wall-street.jpg https://mitsui-global.com/ja/valens-%e3%81%af%e3%83%8b%e3%83%a5%e3%83%bc%e3%83%a8%e3%83%bc%e3%82%af%e8%a8%bc%e5%88%b8%e6%a0%aa%e5%bc%8f%e5%8f%96%e5%bc%95%e6%89%80%e3%81%ab%e3%81%a6%e6%a0%aa%e5%bc%8f%e4%b8%8a%e5%a0%b4%e3%82%92/ 2022-04-22T20:43:44+00:00 https://mitsui-global.com/wp-content/uploads/2021/10/wall-street.jpg https://mitsui-global.com/ja/spire%e3%80%81exactearth%e3%81%ae%e8%b2%b7%e5%8f%8e%e3%81%ab%e3%82%88%e3%82%8a%e4%ba%8b%e6%a5%ad%e6%8b%a1%e5%a4%a7%e3%82%92%e6%8e%a8%e9%80%b2%e3%80%82/ 2022-04-22T20:51:22+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/spire-globe.jpg https://mitsui-global.com/cipias-driver-monitoring-software-now-available-on-ambarellas-system-on-a-chip/ 2022-05-23T17:56:50+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/ja/%e3%82%a2%e3%83%b3%e3%83%90%e3%83%ac%e3%83%a9%e7%a4%be%e3%81%ae%e3%82%b7%e3%82%b9%e3%83%86%e3%83%a0%e3%82%aa%e3%83%b3%e3%83%81%e3%83%83%e3%83%97%e3%81%abcipia%e3%81%ae%e3%83%89%e3%83%a9%e3%82%a4/ 2022-05-25T17:28:26+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/ja/valens%e3%81%8cptk-acquisition-corp-%e3%81%a8%e3%81%aespac%e5%90%88%e4%bd%b5%e3%81%ae%e6%ba%96%e5%82%99%e3%81%a8%e3%81%97%e3%81%a6form-f-4%e7%99%bb%e9%8c%b2%e3%82%92%e5%ae%8c%e4%ba%86%e3%80%82/ 2022-09-26T20:35:34+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/valens-news.jpg https://mitsui-global.com/ja/spire%e3%81%8cspac%e3%82%92%e9%80%9a%e3%81%98%e3%81%a6%e4%b8%8a%e5%a0%b4/ 2022-09-26T20:36:56+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/spire-global-04.jpg https://mitsui-global.com/ja/rallybio%e3%81%8c%e4%b8%8a%e5%a0%b4/ 2022-09-26T20:56:36+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/rallybio-news.jpg https://mitsui-global.com/svante-receives-25m-from-the-government-of-canada-to-support-the-commercialization-and-industrialization-of-their-low-cost-carbon-capture-technology/ 2022-09-27T16:07:59+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/svanteinc-news.jpg https://mitsui-global.com/ja/cipia%e3%81%a8intcomex%e3%81%af%e3%80%81%e3%83%95%e3%83%aa%e3%83%bc%e3%83%88%e7%ae%a1%e7%90%86%e3%81%a8%e3%83%89%e3%83%a9%e3%82%a4%e3%83%90%e3%83%bc%e7%9b%a3%e8%a6%96%e3%81%ab%e5%af%be%e3%81%99/ 2022-09-28T13:51:00+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/LATAM-Cipia-DriverSense-e1650649252235.png https://mitsui-global.com/kaltura-announces-s-1-filing-for-ipo/ 2022-10-14T20:07:52+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Kaltura_group-35.png https://mitsui-global.com/cipia-announces-2-design-wins-from-one-of-chinas-largest-manufacturers/ 2022-10-14T20:08:29+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/valens-announces-plans-to-go-public-through-merger-with-a-spac-special-acquisition-company-ptk-acquisition-corp/ 2022-10-14T20:08:57+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Valens_copper-fiber.jpg https://mitsui-global.com/cipia-has-reached-a-licensing-agreement-with-telematics-company-waylens-to-use-cipias-driver-monitoring-system-dms-driver-sense-in-waylens-automotive-video-platform/ 2022-10-14T20:09:35+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/ja/valens%e7%a4%be%e3%81%af%e7%89%b9%e5%88%a5%e8%b2%b7%e5%8f%8e%e7%9b%ae%e7%9a%84%e4%bc%9a%e7%a4%be%ef%bc%88spac%ef%bc%89%e3%81%a7%e3%81%82%e3%82%8bptk-acquisition-corp-%e3%81%a8%e3%81%ae%e5%90%88/ 2022-10-14T20:17:56+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Valens_copper-fiber.jpg https://mitsui-global.com/ja/cipia%e7%a4%be%e3%81%af%e3%80%81%e3%83%86%e3%83%ac%e3%83%9e%e3%83%86%e3%82%a3%e3%82%af%e3%82%b9%e4%bc%81%e6%a5%ad%e3%81%aewaylens%e3%81%a8%e3%80%81%e5%90%8c%e7%a4%be%e3%81%ae%e3%83%89%e3%83%a9/ 2022-10-14T20:20:42+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/ja/cipia%e7%a4%be%e3%81%af%e8%87%aa%e7%a4%bedms%ef%bc%88%e3%83%89%e3%83%a9%e3%82%a4%e3%83%90%e3%83%bc%e3%83%a2%e3%83%8b%e3%82%bf%e3%83%aa%e3%83%b3%e3%82%b0%e3%82%b7%e3%82%b9%e3%83%86%e3%83%a0%ef%bc%89/ 2022-10-14T20:21:06+00:00 https://mitsui-global.com/wp-content/uploads/2022/05/Cipia_driver_monitoring.jpg https://mitsui-global.com/ja/kaltura%e7%a4%be%e3%81%af%e6%96%b0%e8%a6%8f%e6%a0%aa%e5%bc%8f%e5%85%ac%e9%96%8b%e3%81%ae%e7%82%ba%e3%81%aes-1-%e7%94%b3%e8%ab%8b%e3%82%92%e7%99%ba%e8%a1%a8%e3%80%82/ 2022-10-14T20:21:15+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Kaltura_group-35.png https://mitsui-global.com/ja/bionova%e7%a4%be%e3%81%8c%e4%b8%ad%e5%9b%bd%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%a1%80%e6%b6%b2%e6%82%aa%e6%80%a7%e8%85%ab%e7%98%8d%e3%81%ae%e6%b2%bb%e7%99%82%e8%96%ac%e3%81%a8%e3%81%97%e3%81%a6bn30/ 2022-10-18T13:44:47+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Bionova_HomePage-5.jpg https://mitsui-global.com/bionova-receives-investigational-new-drug-clearance-for-bn301-for-the-treatment-of-hematologic-malignancies-in-china/ 2022-10-18T19:54:18+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Bionova_HomePage-5.jpg https://mitsui-global.com/ja/%e3%82%b9%e3%83%b4%e3%82%a1%e3%83%b3%e3%83%86%e7%a4%be%e3%80%81%e4%bd%8e%e3%82%b3%e3%82%b9%e3%83%88%e7%82%ad%e7%b4%a0%e5%88%86%e9%9b%a2%e5%9b%9e%e5%8f%8e%e6%8a%80%e8%a1%93%e3%81%ae%e5%95%86%e6%a5%ad/ 2022-10-18T19:57:23+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/svanteinc-news.jpg https://mitsui-global.com/gosecure-adds-check-point-to-technology-partnership-ecosystem/ 2022-11-07T14:24:28+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Cybersecurity2-scaled.jpg https://mitsui-global.com/ja/gosecure%e3%80%81technology-partnership-ecosystem%e3%81%abcheck-point%e3%82%92%e8%bf%bd%e5%8a%a0/ 2022-11-07T14:34:55+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Cybersecurity2-scaled.jpg https://mitsui-global.com/ja/svante%e3%81%afchevron-new-energies%e3%82%92%e3%83%aa%e3%83%bc%e3%83%89%e3%81%a8%e3%81%99%e3%82%8b%e3%82%b7%e3%83%aa%e3%83%bc%e3%82%bae%e3%83%a9%e3%82%a6%e3%83%b3%e3%83%89%e3%81%a73%e5%84%841800/ 2022-12-20T17:22:50+00:00 https://mitsui-global.com/wp-content/uploads/2022/12/CarbonCapturePipes-scaled.jpg https://mitsui-global.com/svante-raises-us318m-in-series-e-round-led-by-chevron-new-energies/ 2022-12-20T17:22:52+00:00 https://mitsui-global.com/wp-content/uploads/2022/12/CarbonCapturePipes-scaled.jpg https://mitsui-global.com/bionova-announces-first-patient-doses-in-a-phase-1-2-study-of-bn301-for-the-treatment-of-hematologic-malignancies-in-china/ 2023-03-03T18:47:40+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/ClinicalTrial_FirstDose_Compressed-scaled.jpg https://mitsui-global.com/rallybio-announces-proof-of-concept-achieved-for-rlyb212-a-novel-monoclonal-anti-hpa-1a-antibody-to-prevent-fetal-and-neonatal-alloimmune-thrombocytopenia/ 2023-03-10T18:25:36+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/BabyandMom_compressed-scaled.jpg https://mitsui-global.com/ja/rallybio%e3%81%af%e3%80%81%e8%83%8e%e5%85%90%e3%83%bb%e6%96%b0%e7%94%9f%e5%85%90%e6%9c%9f%e3%81%ae%e8%87%aa%e5%b7%b1%e5%85%8d%e7%96%ab%e6%80%a7%e8%a1%80%e5%b0%8f%e6%9d%bf%e6%b8%9b%e5%b0%91%e7%97%87/ 2023-03-10T18:25:59+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/BabyandMom_compressed-scaled.jpg https://mitsui-global.com/quralis-closes-88-million-series-b-financing-to-advance-precision-medicines-for-neurodegenerative-diseases/ 2023-03-16T21:46:23+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/BoardRoom_Condensed-scaled.jpg https://mitsui-global.com/ja/bionova%e7%a4%be%e3%80%81%e4%b8%ad%e5%9b%bd%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%a1%80%e6%b6%b2%e6%82%aa%e6%80%a7%e8%85%ab%e7%98%8d%e6%b2%bb%e7%99%82%e8%96%acbn301%e3%81%ae%e7%ac%ac1-2%e7%9b%b8/ 2023-05-22T18:32:00+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/ClinicalTrial_FirstDose_Compressed-scaled.jpg https://mitsui-global.com/ja/bn104%e3%80%81%e6%80%a5%e6%80%a7%e9%aa%a8%e9%ab%84%e6%80%a7%e7%99%bd%e8%a1%80%e7%97%85%e3%81%ae%e6%b2%bb%e7%99%82%e8%96%ac%e3%81%a8%e3%81%97%e3%81%a6%e7%b1%b3%e5%9b%bdfda%e3%82%88%e3%82%8a%e5%b8%8c/ 2023-05-25T22:18:15+00:00 https://mitsui-global.com/wp-content/uploads/2023/05/PillsonYellowBackground_Condensed.jpg https://mitsui-global.com/bn104-granted-orphan-drug-designation-by-us-fda-for-the-treatment-of-acute-myeloid-leukemia/ 2023-05-25T22:18:17+00:00 https://mitsui-global.com/wp-content/uploads/2023/05/PillsonYellowBackground_Condensed.jpg https://mitsui-global.com/quralis-receives-health-canada-trial-application-authorization/ 2023-07-10T14:44:37+00:00 https://mitsui-global.com/wp-content/uploads/2022/12/DoctorSmilingCondensed-scaled-e1671558055370.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81%e7%a5%9e%e7%b5%8c%e5%a4%89%e6%80%a7%e7%96%be%e6%82%a3%e3%81%ae%e7%b2%be%e5%af%86%e5%8c%bb%e7%99%82%e3%82%92%e6%8e%a8%e9%80%b2%e3%81%99%e3%82%8b%e3%81%9f%e3%82%818800%e4%b8%87/ 2023-07-10T15:00:00+00:00 https://mitsui-global.com/wp-content/uploads/2023/03/BoardRoom_Condensed-scaled.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%81%8c%e3%82%ab%e3%83%8a%e3%83%80%e4%bf%9d%e5%81%a5%e7%9c%81%e3%81%ae%e6%b2%bb%e9%a8%93%e7%94%b3%e8%ab%8b%e8%aa%8d%e5%8f%af%e3%82%92%e5%8f%96%e5%be%97/ 2023-07-10T15:02:35+00:00 https://mitsui-global.com/wp-content/uploads/2022/12/DoctorSmilingCondensed-scaled-e1671557809537.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81%e6%ac%a7%e5%b7%9e%e9%80%a3%e5%90%88%ef%bc%88eu%ef%bc%89%e3%81%ab%e3%81%8a%e3%81%84%e3%81%a6als%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%83%95%e3%82%a1%e3%83%bc%e3%82%b9/ 2023-07-20T17:23:19+00:00 https://mitsui-global.com/wp-content/uploads/2023/07/woman_wheelchair_droffice_compressed-scaled.jpg https://mitsui-global.com/quralis-receives-clinical-trial-authorisation-cta-in-european-union-eu-for-qrl-201-a-first-in-class-stathmin-2-precision-therapy-for-als/ 2023-07-20T17:23:20+00:00 https://mitsui-global.com/wp-content/uploads/2023/07/woman_wheelchair_droffice_compressed-scaled.jpg https://mitsui-global.com/bionova-announces-%e4%b9%90%e8%88%92%e5%85%8b-belumosudil-mesylate-tablets-approval-by-china-nmpa-for-the-treatment-of-patients-with-chronic-graft-versus-host-disease-cgvhd/ 2023-08-24T15:45:26+00:00 https://mitsui-global.com/wp-content/uploads/2023/08/BioNova-tablet-approval-compressed-scaled.jpg https://mitsui-global.com/ja/bionova%e7%a4%be%e3%80%81%e4%b9%90%e8%88%92%e5%85%8bbelumosudil-mesylate%e9%8c%a0%e3%81%8c%e6%85%a2%e6%80%a7%e7%a7%bb%e6%a4%8d%e7%89%87%e5%af%be%e5%ae%bf%e4%b8%bb%e7%97%85%ef%bc%88cgvhd/ 2023-08-24T15:47:41+00:00 https://mitsui-global.com/wp-content/uploads/2023/08/BioNova-tablet-approval-compressed-scaled.jpg https://mitsui-global.com/bionova-receives-investigational-new-drug-clearance-for-bn104-for-the-treatment-of-acute-leukemia-in-china/ 2023-09-01T21:03:09+00:00 https://mitsui-global.com/wp-content/uploads/2023/08/woman-holding-drug-container-compressed-resized.jpg https://mitsui-global.com/ja/bionova%e7%a4%be%e3%80%81%e4%b8%ad%e5%9b%bd%e3%81%ab%e3%81%8a%e3%81%84%e3%81%a6%e6%80%a5%e6%80%a7%e7%99%bd%e8%a1%80%e7%97%85%e6%b2%bb%e7%99%82%e8%96%acbn104%e3%81%ae%e6%b2%bb%e9%a8%93%e8%96%ac/ 2023-09-01T21:03:55+00:00 https://mitsui-global.com/wp-content/uploads/2023/08/woman-holding-drug-container-compressed-resized.jpg https://mitsui-global.com/ja/beigene%e7%a4%be%e3%81%a8ensem-therapeutics%e7%a4%be%e3%80%81%e5%88%86%e5%8c%96%e5%9e%8bcdk2%e9%98%bb%e5%ae%b3%e5%89%a4%e3%81%ae%e9%96%8b%e7%99%ba%e3%81%ab%e9%96%a2%e3%81%99%e3%82%8b%e6%8f%90-2/ 2023-12-12T19:29:40+00:00 https://mitsui-global.com/wp-content/uploads/2023/12/shaking-hands-compressed.jpg https://mitsui-global.com/beigene-and-ensem-therapeutics-announce-partnership-to-advance-differentiated-cdk2-inhibitor-2/ 2023-12-12T19:30:01+00:00 https://mitsui-global.com/wp-content/uploads/2023/12/shaking-hands-compressed.jpg https://mitsui-global.com/ja/%e7%b1%b3%e5%9b%bd%e3%81%a7%e3%81%ae%e3%82%b9%e3%82%bf%e3%83%bc%e3%83%88%e3%82%a2%e3%83%83%e3%83%97%e6%8a%95%e8%b3%87%e3%83%95%e3%82%a1%e3%83%b3%e3%83%89e12-venture-capital-fund-i-l-p-%e3%81%b8/ 2024-01-19T18:54:42+00:00 https://mitsui-global.com/wp-content/uploads/2024/01/E12Team.png https://mitsui-global.com/mitsui-invests-in-e12-ventures-a-us-based-venture-capital-fund/ 2024-01-19T18:54:44+00:00 https://mitsui-global.com/wp-content/uploads/2024/01/E12Team.png https://mitsui-global.com/qd-laser-announces-ipo-on-tokyo-stock-exchanges-mothers-index/ 2024-03-04T23:47:17+00:00 https://mitsui-global.com/wp-content/uploads/2022/09/mission_img_1.jpg https://mitsui-global.com/ja/qd%e3%83%ac%e3%83%bc%e3%82%b6%e3%81%af%e6%9d%b1%e4%ba%ac%e8%a8%bc%e5%88%b8%e5%8f%96%e5%bc%95%e6%89%80%e3%83%9e%e3%82%b6%e3%83%bc%e3%82%ba%e5%b8%82%e5%a0%b4%e3%81%b8%e3%81%ae%e6%96%b0%e8%a6%8f%e4%b8%8a/ 2024-03-04T23:49:05+00:00 https://mitsui-global.com/wp-content/uploads/2022/09/mission_img_1.jpg https://mitsui-global.com/ja/qd-laser%e3%81%af%e6%9d%b1%e4%ba%ac%e8%a8%bc%e5%88%b8%e5%8f%96%e5%bc%95%e6%89%80%e3%83%9e%e3%82%b6%e3%83%bc%e3%82%ba%e5%b8%82%e5%a0%b4%e3%81%b8%e3%81%ae%e6%96%b0%e8%a6%8f%e4%b8%8a%e5%a0%b4%e6%89%bf/ 2024-03-04T23:49:25+00:00 https://mitsui-global.com/wp-content/uploads/2022/09/mission_img_1.jpg https://mitsui-global.com/qd-laser-receives-approval-to-go-public-on-the-tokyo-stock-exchange-mothers-market/ 2024-03-04T23:50:05+00:00 https://mitsui-global.com/wp-content/uploads/2022/09/mission_img_1.jpg https://mitsui-global.com/quralis-receives-clinical-trial-authorisation-cta-in-the-u-k-for-qrl-201-a-first-in-class-stathmin-2-precision-therapy-for-als/ 2024-03-04T23:57:48+00:00 https://mitsui-global.com/wp-content/uploads/2023/07/HappyDoctorEvalPt-Compressed_Resized-1.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81%e8%8b%b1%e5%9b%bd%e3%81%ab%e3%81%8a%e3%81%84%e3%81%a6als%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%83%95%e3%82%a1%e3%83%bc%e3%82%b9%e3%83%88%e3%83%bb%e3%82%a4%e3%83%b3%e3%83%bb/ 2024-03-04T23:59:33+00:00 https://mitsui-global.com/wp-content/uploads/2023/07/HappyDoctorEvalPt-Compressed_Resized-1.jpg https://mitsui-global.com/quralis-announces-first-patient-dosed-with-qrl-201-a-first-in-class-stathmin-2-precision-therapy-for-als/ 2024-03-05T00:51:56+00:00 https://mitsui-global.com/wp-content/uploads/2023/05/pexels-cottonbro-studio-compressed.jpg https://mitsui-global.com/rallybio-in-licensing-potential-first-in-class-antibody-from-sanofi/ 2024-03-05T18:00:05+00:00 https://mitsui-global.com/wp-content/uploads/2022/01/rally-bio-conference-room.jpg https://mitsui-global.com/ja/%e3%83%a9%e3%83%aa%e3%83%bc%e3%83%90%e3%82%a4%e3%82%aa%e7%a4%be%e3%81%8c%e6%96%b0%e3%81%9f%e3%81%ab%e3%82%b5%e3%83%8e%e3%83%95%e3%82%a3%e7%a4%be%e3%81%8b%e3%82%89%e6%8a%97%e4%bd%93%e5%8c%bb%e8%96%ac/ 2024-03-05T18:02:20+00:00 https://mitsui-global.com/wp-content/uploads/2022/01/rally-bio-conference-room.jpg https://mitsui-global.com/rallybio-announces-clinical-proof-of-concept-for-rlyb211-an-anti-hpa-1a-antibody-for-the-prevention-of-fetal-and-neonatal-alloimmune-thrombocytopenia-fnait/ 2024-03-05T18:22:41+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/rallybio-news.jpg https://mitsui-global.com/ja/rallybio%e3%80%81%e6%8a%97hpa-1a%e6%8a%97%e4%bd%93%e3%80%8crlyb211%e3%80%8d%e3%81%ae%e8%83%8e%e5%85%90%e3%83%bb%e6%96%b0%e7%94%9f%e5%85%90%e5%85%8d%e7%96%ab%e6%80%a7%e8%a1%80%e5%b0%8f%e6%9d%bf/ 2024-03-05T18:22:41+00:00 https://mitsui-global.com/wp-content/uploads/2022/04/rallybio-news.jpg https://mitsui-global.com/quralis-announces-first-in-human-dose-in-phase-1-clinical-trial-of-qrl-101-a-first-in-class-kv7-precision-therapy-for-als/ 2024-03-07T00:54:32+00:00 https://mitsui-global.com/wp-content/uploads/2023/01/OralDosePic-scaled-e1674486126866.jpg https://mitsui-global.com/ja/quralis%e5%ae%a3%e5%b8%83-qrl-101%e6%98%af%e4%b8%80%e7%a7%8d%e6%b2%bb%e7%96%97als%e7%9a%84kv7%e7%b2%be%e5%87%86%e7%96%97%e6%b3%95%ef%bc%8cqrl-101%e7%ac%ac%e4%b8%80%e6%9c%9f%e4%b8%b4%e5%ba%8a%e8%af%95/ 2024-03-07T00:57:08+00:00 https://mitsui-global.com/wp-content/uploads/2023/01/OralDosePic-scaled-e1674486126866.jpg https://mitsui-global.com/cipia-announces-driver-sense-to-be-integrated-in-2-additional-car-models-by-a-leading-chinese-oem/ 2024-03-07T17:42:11+00:00 https://mitsui-global.com/wp-content/uploads/2022/03/car.jpg https://mitsui-global.com/ja/cipia-%e3%81%af%e6%96%b0%e8%a6%8f%e6%a0%aa%e5%bc%8f%e5%85%ac%e9%96%8b%e3%82%92%e7%99%ba%e8%a1%a8%e3%81%97%e3%81%be%e3%81%97%e3%81%9f%e3%80%82/ 2024-03-07T17:43:18+00:00 https://mitsui-global.com/wp-content/uploads/2022/03/car.jpg https://mitsui-global.com/valens-announces-design-completion-of-new-chipsets-that-comply-with-mipi-alliance-a-phy-standards-for-adas-advanced-driver-assistance-systems/ 2024-03-11T22:06:40+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Valens_copper-fiber.jpg https://mitsui-global.com/ja/valens%e7%a4%be%e3%81%af%e3%80%81adas%ef%bc%88%e5%85%88%e9%80%b2%e9%81%8b%e8%bb%a2%e6%94%af%e6%8f%b4%e3%82%b7%e3%82%b9%e3%83%86%e3%83%a0%ef%bc%89%e5%90%91%e3%81%91%e3%81%aemipi-alliance-a-phy/ 2024-03-11T22:08:58+00:00 https://mitsui-global.com/wp-content/uploads/2022/10/Valens_copper-fiber.jpg https://mitsui-global.com/leash-biosciences-announces-9-3-million-seed-financing-to-pioneer-ai-driven-medicinal-chemistry/ 2024-04-22T18:47:03+00:00 https://mitsui-global.com/wp-content/uploads/2024/04/scientists-looking-at-microscope-compressed-scaled.jpg https://mitsui-global.com/ja/leash-biosciences%e7%a4%be%e3%80%81ai%e3%82%92%e6%b4%bb%e7%94%a8%e3%81%97%e3%81%9f%e8%96%ac%e5%8c%96%e5%ad%a6%e3%81%ae%e9%96%8b%e6%8b%93%e3%81%ab%e5%90%91%e3%81%91930%e4%b8%87%e3%83%89%e3%83%ab/ 2024-05-01T14:36:58+00:00 https://mitsui-global.com/wp-content/uploads/2024/04/scientists-looking-at-microscope-compressed-scaled.jpg https://mitsui-global.com/ja/quralis%e3%81%af%e3%80%81als%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%83%95%e3%82%a1%e3%83%bc%e3%82%b9%e3%83%88%e3%83%bb%e3%82%a4%e3%83%b3%e3%83%bb%e3%82%af%e3%83%a9%e3%82%b9%e3%81%aestathmin-2%e7%b2%be/ 2024-05-09T21:19:47+00:00 https://mitsui-global.com/wp-content/uploads/2023/05/pexels-cottonbro-studio-compressed.jpg https://mitsui-global.com/reunion-neuroscience-inc-announces-103-million-series-a-financing-co-led-by-mpm-bioimpact-and-novo-holdings/ 2024-05-30T14:25:15+00:00 https://mitsui-global.com/wp-content/uploads/2024/05/people-signing-compressed-and-resized.jpg https://mitsui-global.com/reunion-neuroscience-announces-publication-of-results-from-early-preclinical-studies-demonstrating-the-potential-of-re104-for-development-in-depressive-disorders/ 2024-05-30T14:32:52+00:00 https://mitsui-global.com/wp-content/uploads/2024/05/scientist-doing-research-resized-and-compressed.jpg https://mitsui-global.com/ja/reunion-neuroscience%e7%a4%be%e3%81%af%e3%80%81mpm-bioimpact%e3%81%a8novo-holdings%e3%81%8c%e3%83%aa%e3%83%bc%e3%83%89%e3%82%a4%e3%83%b3%e3%83%99%e3%82%b9%e3%82%bf%e3%83%bc%e3%82%92%e5%8b%99%e3%82%81/ 2024-05-30T20:34:10+00:00 https://mitsui-global.com/wp-content/uploads/2024/05/people-signing-compressed-and-resized.jpg https://mitsui-global.com/ja/reunion-neuroscience%e7%a4%be%e3%80%81re104%e3%81%ae%e3%81%86%e3%81%a4%e7%97%85%e6%b2%bb%e7%99%82%e8%96%ac%e3%81%a8%e3%81%97%e3%81%a6%e3%81%ae%e5%8f%af%e8%83%bd%e6%80%a7%e3%82%92%e7%a4%ba%e3%81%99/ 2024-05-30T20:34:50+00:00 https://mitsui-global.com/wp-content/uploads/2024/05/scientist-doing-research-resized-and-compressed.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81als-%e3%81%8a%e3%82%88%e3%81%b3-ftd-%e3%81%ab%e3%81%8a%e3%81%84%e3%81%a6-unc13a-%e6%a9%9f%e8%83%bd%e3%82%92%e5%9b%9e%e5%be%a9%e3%81%95%e3%81%9b%e3%82%8b%e3%83%95%e3%82%a1/ 2024-06-04T21:24:52+00:00 https://mitsui-global.com/wp-content/uploads/2024/06/Finger-pointing-brain-scan-compressed-and-resized.jpg https://mitsui-global.com/quralis-grants-lilly-exclusive-global-license-for-qrl-204-a-potentially-first-in-class-precision-therapy-that-restores-unc13a-function-in-als-and-ftd/ 2024-06-04T21:24:53+00:00 https://mitsui-global.com/wp-content/uploads/2024/06/Finger-pointing-brain-scan-compressed-and-resized.jpg https://mitsui-global.com/closing-of-mgi-beijing-office/ 2024-10-30T20:00:49+00:00 https://mitsui-global.com/wp-content/uploads/2024/10/BeijingNightime-1-scaled.jpg https://mitsui-global.com/ja/mgi%e5%8c%97%e4%ba%ac%e4%ba%8b%e5%8b%99%e6%89%80%e9%96%89%e9%8e%96%e3%81%ae%e3%81%8a%e7%9f%a5%e3%82%89%e3%81%9b/ 2024-10-31T19:50:10+00:00 https://mitsui-global.com/wp-content/uploads/2024/10/BeijingNightime-1-scaled.jpg https://mitsui-global.com/quralis-doses-first-patient-with-als-in-phase-1-clinical-trial-evaluating-qrl-101-a-first-in-class-kv7-precision-therapy-for-als/ 2024-12-17T14:52:34+00:00 https://mitsui-global.com/wp-content/uploads/2024/12/preparing-medicine-compressed-and-resized.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81als%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%83%95%e3%82%a1%e3%83%bc%e3%82%b9%e3%83%88%e3%83%bb%e3%82%a4%e3%83%b3%e3%83%bb%e3%82%af%e3%83%a9%e3%82%b9%e3%81%aekv7%e7%b2%be/ 2025-02-24T17:07:35+00:00 https://mitsui-global.com/wp-content/uploads/2024/12/preparing-medicine-compressed-and-resized.jpg https://mitsui-global.com/quralis-announces-topline-data-from-its-phase-1-clinical-trial-of-qrl-101-evaluating-biomarkers-of-als-and-epilepsy-in-healthy-volunteers/ 2025-03-17T19:06:17+00:00 https://mitsui-global.com/wp-content/uploads/2025/03/Lab-testing-compressed-and-resized.png https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81%e5%81%a5%e5%ba%b7%e3%81%aa%e3%83%9c%e3%83%a9%e3%83%b3%e3%83%86%e3%82%a3%e3%82%a2%e3%82%92%e5%af%be%e8%b1%a1%e3%81%a8%e3%81%97%e3%81%9fals%e5%8f%8a%e3%81%b3%e3%81%a6%e3%82%93/ 2025-03-17T19:06:45+00:00 https://mitsui-global.com/wp-content/uploads/2025/03/Lab-testing-compressed-and-resized.png https://mitsui-global.com/ensem-therapeutics-announces-u-s-fda-ind-clearance-to-initiate-clinical-development-of-etx-636/ 2025-04-24T23:07:12+00:00 https://mitsui-global.com/wp-content/uploads/2025/04/Drugs-on-shelves-compressed-and-resized.jpg https://mitsui-global.com/ja/ensem-therapeutics%e3%80%81etx-636%e3%81%ae%e8%87%a8%e5%ba%8a%e9%96%8b%e7%99%ba%e3%82%92%e9%96%8b%e5%a7%8b%e3%81%99%e3%82%8b%e3%81%9f%e3%82%81%e3%81%ae%e7%b1%b3%e5%9b%bdfda-ind%e6%89%bf%e8%aa%8d/ 2025-04-24T23:07:31+00:00 https://mitsui-global.com/wp-content/uploads/2025/04/Drugs-on-shelves-compressed-and-resized.jpg https://mitsui-global.com/stately-bio-raises-12m-seed-to-develop-next-generation-regenerative-medicines-with-ml-powered-cellular-imaging-platform/ 2025-05-07T19:13:02+00:00 https://mitsui-global.com/wp-content/uploads/2025/05/Cells-compressed-and-resized.jpg https://mitsui-global.com/ja/stately-bio%e3%80%81ml%e3%82%92%e6%b4%bb%e7%94%a8%e3%81%97%e3%81%9f%e7%b4%b0%e8%83%9e%e3%82%a4%e3%83%a1%e3%83%bc%e3%82%b8%e3%83%b3%e3%82%b0%e3%83%97%e3%83%a9%e3%83%83%e3%83%88%e3%83%95%e3%82%a9/ 2025-05-07T19:14:58+00:00 https://mitsui-global.com/wp-content/uploads/2025/05/Cells-compressed-and-resized.jpg https://mitsui-global.com/ellipsis-health-unveils-sage-the-emotionally-intelligent-ai-care-manager-backed-by-45m-from-salesforce-khosla-ventures-and-cvs-ventures/ 2025-06-17T01:25:55+00:00 https://mitsui-global.com/wp-content/uploads/2025/06/a-computer-circuit-board-with-a-brain-on-it-compressed-and-resized-scaled.jpg https://mitsui-global.com/ja/ellipsis-health%e3%81%af%e3%80%81salesforce%e3%80%81khosla-ventures%e3%80%81cvs-ventures%e3%81%8b%e3%82%894500%e4%b8%87%e3%83%89%e3%83%ab%e3%81%ae%e8%b3%87%e9%87%91%e8%aa%bf%e9%81%94%e3%82%92/ 2025-06-20T18:08:44+00:00 https://mitsui-global.com/wp-content/uploads/2025/06/a-computer-circuit-board-with-a-brain-on-it-compressed-and-resized-scaled.jpg https://mitsui-global.com/servier-to-acquire-exclusive-worldwide-rights-of-bionovas-bn104-a-potential-best-in-class-menin-inhibitor/ 2025-06-23T20:11:57+00:00 https://mitsui-global.com/wp-content/uploads/2025/06/a-group-of-people-sitting-around-a-table-resized-and-compressed-scaled.jpg https://mitsui-global.com/ja/servier%e7%a4%be%e3%80%81%e3%83%99%e3%82%b9%e3%83%88%e3%83%bb%e3%82%a4%e3%83%b3%e3%83%bb%e3%82%af%e3%83%a9%e3%82%b9%e3%81%ae%e3%83%a1%e3%83%8b%e3%83%b3%e9%98%bb%e5%ae%b3%e5%89%a4%e3%81%a8%e3%81%aa/ 2025-06-23T20:12:48+00:00 https://mitsui-global.com/wp-content/uploads/2025/06/a-group-of-people-sitting-around-a-table-resized-and-compressed-scaled.jpg https://mitsui-global.com/reunion-neuroscience-presented-re104-phase-1-data-at-the-2024-american-college-of-neuropsychopharmacology-acnp-63rd-annual-meeting/ 2025-08-19T00:04:40+00:00 https://mitsui-global.com/wp-content/uploads/2024/12/people-taking-notes-at-a-conference-compressed-and-resized.jpg https://mitsui-global.com/ja/reunion-neuroscience%e7%a4%be%e3%80%812024%e5%b9%b4%e7%b1%b3%e5%9b%bd%e7%a5%9e%e7%b5%8c%e7%b2%be%e7%a5%9e%e8%96%ac%e7%90%86%e5%ad%a6%e4%bc%9a%ef%bc%88acnp%ef%bc%89%e7%ac%ac63%e5%9b%9e%e5%b9%b4/ 2025-08-19T00:06:36+00:00 https://mitsui-global.com/wp-content/uploads/2024/12/people-taking-notes-at-a-conference-compressed-and-resized.jpg https://mitsui-global.com/ja/reunion-neuroscience%e7%a4%be%e3%80%81%e7%94%a3%e5%be%8c%e3%81%86%e3%81%a4%e7%97%85%ef%bc%88ppd%ef%bc%89%e6%b2%bb%e7%99%82%e8%96%acre104%e3%81%aereconnect%e7%ac%ac2%e7%9b%b8%e8%a9%a6%e9%a8%93%e3%81%a7/ 2025-08-19T00:12:22+00:00 https://mitsui-global.com/wp-content/uploads/2025/08/woman-sitting-on-bed-compressed-and-resized.jpg https://mitsui-global.com/reunion-neuroscience-announces-positive-topline-results-from-reconnect-phase-2-clinical-trial-of-re104-for-the-treatment-of-postpartum-depression-ppd/ 2025-08-19T00:12:44+00:00 https://mitsui-global.com/wp-content/uploads/2025/08/woman-sitting-on-bed-compressed-and-resized.jpg https://mitsui-global.com/quralis-demonstrates-effects-on-disease-progression-and-target-engagement-in-anqur-clinical-trial-of-qrl-201-a-first-in-class-precision-medicine-in-development-for-sporadic-als/ 2026-02-27T00:17:57+00:00 https://mitsui-global.com/wp-content/uploads/2026/02/a-man-looking-at-the-computer-in-a-lab-resized-and-compressed.jpg https://mitsui-global.com/ja/mahzi-therapeutics%e7%a4%be%e3%80%81pitt-hopkins%e7%97%87%e5%80%99%e7%be%a4%e3%82%92%e5%af%be%e8%b1%a1%e3%81%a8%e3%81%97%e3%81%9fmz-1866%e3%81%ae%e7%ac%ac1-2%e7%9b%b8unite%e8%a9%a6%e9%a8%93%e3%81%ab/ 2026-03-02T22:25:22+00:00 https://mitsui-global.com/wp-content/uploads/2026/02/a-person-holding-a-syringe-resized-and-compressed.jpg https://mitsui-global.com/ja/quralis%e7%a4%be%e3%80%81%e6%95%a3%e7%99%ba%e6%80%a7als%e3%82%92%e5%af%be%e8%b1%a1%e3%81%a8%e3%81%97%e3%81%a6%e9%96%8b%e7%99%ba%e4%b8%ad%e3%81%ae%e3%83%95%e3%82%a1%e3%83%bc%e3%82%b9%e3%83%88%e3%83%bb/ 2026-03-02T22:42:22+00:00 https://mitsui-global.com/wp-content/uploads/2026/02/a-man-looking-at-the-computer-in-a-lab-resized-and-compressed.jpg https://mitsui-global.com/__trashed/ 2026-03-03T17:01:23+00:00 https://mitsui-global.com/wp-content/uploads/2026/02/a-person-holding-a-syringe-resized-and-compressed.jpg https://mitsui-global.com/tacit-therapeutics-announces-series-a-financing-to-advance-rna-trans-splicing-medicines-for-inherited-diseases/ 2026-03-13T00:31:42+00:00 https://mitsui-global.com/wp-content/uploads/2026/03/RNA-image-compressed-and-resized.jpg https://mitsui-global.com/ja/tacit-therapeutics%e7%a4%be%e3%80%81%e9%81%ba%e4%bc%9d%e6%80%a7%e7%96%be%e6%82%a3%e5%90%91%e3%81%91rna%e3%83%88%e3%83%a9%e3%83%b3%e3%82%b9%e3%82%b9%e3%83%97%e3%83%a9%e3%82%a4%e3%82%b7%e3%83%b3/ 2026-06-03T18:34:38+00:00 https://mitsui-global.com/wp-content/uploads/2026/03/RNA-image-compressed-and-resized.jpg https://mitsui-global.com/waypoint-bio-raises-20m-to-run-three-car-t-trials-in-china/ 2026-06-04T00:55:58+00:00 https://mitsui-global.com/wp-content/uploads/2026/06/cells-2-compressed-and-resized.jpg https://mitsui-global.com/ja/waypoint-bio%e7%a4%be%e3%80%81%e4%b8%ad%e5%9b%bd%e3%81%a7%e3%81%ae3%e4%bb%b6%e3%81%aecar-t%e8%87%a8%e5%ba%8a%e8%a9%a6%e9%a8%93%e5%ae%9f%e6%96%bd%e3%81%ab%e5%90%91%e3%81%912000%e4%b8%87%e3%83%89/ 2026-06-04T01:03:18+00:00 https://mitsui-global.com/wp-content/uploads/2026/06/cells-2-compressed-and-resized.jpg